Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation.
The company is harnessing the power of interleukin-10 (IL-10), a potent cytokine that acts as a master regulator for multiple inflammatory pathways, to address the root cause of inflammation and subsequently restore homeostasis in the immune system.
Xalud’s lead product candidate, XT-150, is a locally injectable plasmid DNA gene therapy expressing IL-10 to addresses pathologic inflammation and pain.
Company Details
- Employees
- 6
- Address
- 40 West 57th Street,
- Industry
- Biotechnology
- Website
- http://xaludthera.com
- Keywords
- Waltham.
- HQ
- New York , New York
Xalud Therapeutics, Inc. Questions
Xalud Therapeutics, Inc.'s website is http://xaludthera.com
Xalud Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/xalud-therapeutics-inc.
Xalud Therapeutics, Inc. has
6 employees.
View email and phone details for 6
employees at Xalud Therapeutics, Inc..
Xalud Therapeutics, Inc.'s industry is
Biotechnology
Xalud Therapeutics, Inc.'s top competitors are
Sparian Biosciences,
Ppd,
Insmed Incorporated,
Ultragenyx,
Spine Biopharma,
Candel Therapeutics,
Tg Therapeutics, Inc.,
Exegenesis Bio,
Siga Technologies,
Siga.
Xalud Therapeutics, Inc.'s categories are Biotechnology
